The Journal of Critical Limb Ischemia is a digital peer-reviewed journal providing access to full articles without charge and is registered with all major Internet search engines.
Statements and opinions expressed by authors are their own and not necessarily those of the publisher, editorial staff, or any member of the Editorial Advisory Board. The publisher of the Journal of Critical Limb Ischemia accepts no responsibility for statements made by contributors or claims made by advertisers, nor does the publication of advertisements constitute or imply endorsement. Manuscripts are accepted for publication in the Journal of Critical Limb Ischemia with the understanding that their content, all or in part, has not been published elsewhere and will not be published elsewhere, except in abstract form or by the express consent of the Managing Editor.
All manuscripts submitted for publication must include the following statement signed by the senior author within the cover letter: “The undersigned author transfers all copyright ownership of the manuscript entitled (title of article) to HMP Global in the event the work is published. The author warrants that the article is original, is not under consideration by another journal, and has not been previously published. I sign for and accept responsibility for releasing this material on behalf of any and all co-authors.”
Best practices. Manuscripts must conform to Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations). In addition, the Journal of Critical Limb Ischemia adheres to COPE core practices (scholarly research and publications guidelines) as a guide to the highest standards in publication ethics.
Peer Review Policy
All submissions are peer reviewed by 2 to 3 referees who are experts in the field. The peer-review process is single-anonymized. This is the most common form of peer review among science journals. Acceptance is based upon significance and originality. If an article is accepted for publication, the corresponding author will be notified via e-mail through Editorial Manager and the content revision requirements supplied by the peer reviewers will be included. Editorial revisions will be made to articles accepted as an aid to clarity. If an article is not accepted, the corresponding author will be notified by e-mail through Editorial Manager. To avoid significant delays in the peer review or editorial processing of your manuscript, please adhere to the submission guidelines.
Ethics and Conflicts of Interest/Disclosures
Authors are responsible for all content submitted. Opinions expressed by authors are their own and not necessarily those of HMP Global, the editorial staff, or any member of the editorial advisory board. No claims made by authors or advertisers are guaranteed by the publisher or the editors. Authors must comply with Food and Drug Administration guidelines, human studies guidelines and animal welfare regulations of the authors’ institution.
Authors should indicate in the paper that human subjects have given informed consent and that the authors have conformed to all appropriate institutional guidelines, including information about Institutional Review Board approval.
A statement acknowledging financial interest in products/companies relevant to submitted research must be disclosed to the editors when the paper is submitted. Any financial interest which may be interpreted as a conflict of interest, including stock ownership, consultancies, patent-licensing relationships, and other equity interests, must be disclosed in the cover letter. If no conflicts of interest exist, then this must be stated.
Corrections and Retractions
Published articles that require a revision or correction due to editorial, production, or scientific errors will be revised accordingly and include a published notice of correction with all appropriate additional citation information as needed. Notifications will include the nature of the error or revision.
In the event an article is found to include serious errors, including cases of scientific misconduct, plagiarism, and/or unsubstantiated data, the article will be removed and a notice of retraction with reason will be posted. Articles may be republished following a retraction if all errors are corrected at the discretion of the editors.
Questions or concerns regarding content appearing in the Journal of Critical Limb Ischemia should be submitted directly to the Managing Editor at email@example.com
AUTHOR submissions / link to submit manuscripts via Editorial Manager:
REVIEWER assignments / link to Editorial Manager: